Semler Scientific, Inc.
SMLRNASDAQHealthcare
$20.33
$-1.04(-4.87%)
Market Cap$310745920
P/E Ratio—
52W High$65.98
52W Low$14.885
Semler Scientific, Inc. (SMLR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SMLR · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $40.90M | $20.58M | $14.32M | $17.22M | $14.01M |
| Depreciation & Amort. | $0.58M | $0.60M | $0.59M | $0.63M | $0.58M |
| Stock-Based Comp. | $0.86M | $0.00M | $0.74M | $0.75M | $0.25M |
| Change in Working Capital | $1.19M | ($3.74M) | $1.67M | ($4.58M) | ($1.73M) |
| Net Cash from Operations | $24.41M | $17.82M | $17.46M | $16.06M | $15.11M |
| Investing Activities | |||||
| Capital Expenditure | ($189.75M) | ($0.83M) | ($2.16M) | ($0.82M) | ($0.76M) |
| Purchases of Investments | ($0.50M) | ($57.87M) | ($24.68M) | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $78.09M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($189.98M) | $18.40M | ($26.84M) | ($0.82M) | ($1.01M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | ($1.95M) | ($4.99M) | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $117.19M | ($1.90M) | ($4.94M) | $0.01M | $0.23M |
| Free Cash Flow | |||||
| Free Cash Flow | ($165.34M) | $16.99M | $15.30M | $15.23M | $14.36M |
| FCF Margin %(computed) | -293.71% | 24.92% | 27.00% | 28.72% | 37.19% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Semler Scientific, Inc. data
About Semler Scientific, Inc. (SMLR) Cash Flow Statement
Semler Scientific, Inc. generated operating cash flow of $0.02B and free cash flow of ($0.17B) for 2024 — a FCF margin of -293.71%. Capital expenditure was ($0.19B).
Frequently asked questions
SMLR · 4 questionsSemler Scientific, Inc. generated free cash flow of ($0.17B) for 2024, down 1073.1% year-over-year.
SMLR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10